The share price of Australian Pharmaceutical Industries Ltd(ASX: API) has been on a roller coaster ride over the last 2 years. After reaching a high of $2.38 in May 2017, the companys shares were sold-off on fears that it would not meet profit expectations amid an increasingly difficult trading environment in its retail and pharmacy distribution businesses.Rival Sigma Healthcare Ltd(ASX: SIG)has fared even worse following the loss of its Chemist Warehouse supply contract. After bottoming at $1.23 in late April 2018, shares of Australian Pharmaceutical Industries have enjoyed a bounce with the $127 million acquisition of Clearskincare Clinics in
The share price of Australian Pharmaceutical Industries Ltd (ASX: API) has been on a roll…
Read the full article at: https://www.fool.com.au/2018/10/22/is-it-time-to-buy-shares-in-australian-pharmaceutical-industries-ltd-asxapi/